Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Immune Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06671054
What this trial is testing

A Dose Response Study to Evaluate the Efficacy and Safety of Oral AP1189 Administered in Disease-Modifying Anti-Rheumatic Drug (DMARD) naïve Participants Participants With Early Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis (RA)
SynAct Pharma Aps 240
Testing effectiveness (Phase 2)Ended earlyNCT00196651
What this trial is testing

HIV Immune and Virological Responses Following the Administration of IL-2 Either Alone or Combined to ALVAC-HIV 1433 and HIV Lipopeptides in Patients Treated Early With HAART During Primary Infection

Who this might be right for
HIV Infection
French National Agency for Research on AIDS and Viral Hepatitis 60
Early research (Phase 1)Study completedNCT00117429
What this trial is testing

Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV Infections
Marcus Altfeld, M.D., Ph.D. 20
Testing effectiveness (Phase 2)Study completedNCT00243594
What this trial is testing

Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection

Who this might be right for
Melanoma Stage III or IV
Radboud University Medical Center 40
Large-scale testing (Phase 3)Study completedNCT00960440
What this trial is testing

Study of CP-690,550 Versus Placebo In Rheumatoid Arthritis Patients On Background Methotrexate With Inadequate Response To Tumor Necrosis Factor (TNF) Inhibitors

Who this might be right for
Arthritis, Rheumatoid
Pfizer 399
Testing effectiveness (Phase 2)Ended earlyNCT00779220
What this trial is testing

Evaluate the Efficacy, Safety and Pharmacokinetics/Pharmacodynamics (PK/PD) of Ocrelizumab in Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Chugai Pharmaceutical 152
Large-scale testing (Phase 3)Study completedNCT03830203
What this trial is testing

Comparative Study of BAT1806 to RoActemra® in Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate

Who this might be right for
Rheumatoid Arthritis
Bio-Thera Solutions 621
Testing effectiveness (Phase 2)Study completedNCT00518154
What this trial is testing

Pilot Study of Pyridostigmine Upon Immune Activation in HIV-1 Patients Who Have an Inadequate Immune Response

Who this might be right for
HIV Infections
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 7
Testing effectiveness (Phase 2)Study completedNCT02949973
What this trial is testing

Aurinia Early Urinary Protein Reduction Predicts Response

Who this might be right for
Lupus Nephritis
Aurinia Pharmaceuticals Inc. 10
Post-approval studies (Phase 4)Study completedNCT01089023
What this trial is testing

Tocilizumab as Monotherapy or in Combination With DMARDs in Patients With Moderate to Severe Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 95
Large-scale testing (Phase 3)Ended earlyNCT00603525
What this trial is testing

Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to TNF-α Antagonist Therapy

Who this might be right for
Arthritis, Rheumatoid
GlaxoSmithKline 169
Large-scale testing (Phase 3)Study completedNCT00642460
What this trial is testing

RoActemra/Actemra (Tocilizumab) in Patients With Active Systemic Juvenile Idiopathic Arthritis (JIA)

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 112
Testing effectiveness (Phase 2)Study completedNCT05279417
What this trial is testing

ATI-450 Plus Methotrexate (MTX) Versus Placebo Plus MTX in Participants With Moderate to Severe Active Rheumatoid Arthritis (RA)

Who this might be right for
Rheumatoid Arthritis
Aclaris Therapeutics, Inc. 251
Not applicableLooking for participantsNCT03913962
What this trial is testing

Health and Exercise Response in Children With Chronic and Auto-immune Pathologies

Who this might be right for
Juvenile Idiopathic ArthritisDiabetesInflammatory Bowel Disease+2 more
University Hospital, Clermont-Ferrand 300
Large-scale testing (Phase 3)Ended earlyNCT05246280
What this trial is testing

Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RA

Who this might be right for
Rheumatoid Arthritis
Navidea Biopharmaceuticals 169
Not applicableStudy completedNCT02740686
What this trial is testing

Changes in Inflammatory Markers During Pulmonary Rehabilitation Based on Exacerbation States in COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
University of Lincoln 85
Not applicableLooking for participantsNCT06911970
What this trial is testing

Impact of Aerobic Exercise on the Anticancer Immune Response in Patients Receiving Cancer Treatment

Who this might be right for
Colorectal CancerBreast CancerNon Metastatic Cancer
Université de Sherbrooke 44
Testing effectiveness (Phase 2)Study completedNCT01668641
What this trial is testing

Dose-ranging Study With GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients

Who this might be right for
Rheumatoid Arthritis
Lakefront Biotherapeutics NV 91
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07748728
What this trial is testing

TLL-018 in Patients With Moderate to Severe Active Rheumatoid Arthritis With Inadequate Response or Intolerance to csDMARDs

Who this might be right for
Rheumatoid Arthritis (RA)
Hangzhou Highlightll Pharmaceutical Co., Ltd 90
Testing effectiveness (Phase 2)Study completedNCT05374785
What this trial is testing

Efficacy and Safety Study Comparing CPL409116 to Placebo in Participants With Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Celon Pharma SA 106
Next Page